Decreased intracellular iron availability suppresses epithelial cell surface plasmin generation: Transcriptional and post-transcriptional effects on u-PA and PAI-1 expression

American Journal of Respiratory Cell and Molecular Biology

Volumn 21, Issue 2, 1999, Pages 275-282

  Hasegawa, Takashi ^a   Sorensen, Lise ^a   Ooi, Hidemi ^a   Marshall, Bruce C ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHELATING AGENT; DEFEROXAMINE; INTERLEUKIN 1; IRON; MESSENGER RNA; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; UROKINASE;

ARTICLE; BIOAVAILABILITY; BIOSYNTHESIS; CELL CULTURE; CULTURE MEDIUM; DRUG ANTAGONISM; EPITHELIUM CELL; GENETIC TRANSCRIPTION; HUMAN; IMMUNOLOGY; METABOLISM; RNA PROCESSING; TIME;

BIOLOGICAL AVAILABILITY; CHELATING AGENTS; CULTURE MEDIA, SERUM-FREE; DEFEROXAMINE; EPITHELIAL CELLS; HUMANS; INTERLEUKIN-1; IRON; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0033174283     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.21.2.3445     Document Type: Article

References (39)

1. Kluger, M. J., and J. J. Bullen. 1987. Clinical and physiological aspects. In Iron and Infection: Molecular, Physiological, and Clinical Aspects. J. Bullen and E. Griffiths, editors. John Wiley and Sons, New York.
2. Klausner, R., T. Ronault, and J. Harford. 1993. Regulating the fate of mRNA: the control of cellular iron metabolism. Cell 72:19-28.
3. Hentze, M., and L. Kuhn. 1996. Molecular control of vertebrate iron metabolism: mRNA based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc. Natl. Acad. Sci. USA 92:8175-8182.
4. Gardner, P. R., D.-D. H. Nguyen, and C. W. White. 1994. Aconitase is a sensitive and critical target of oxygen poisoning in cultured mammalian cells and in rat lungs. Proc. Natl. Acad. Sci. USA 91:12248-12252.
5. Weiss, G., G. Werner-Felmayer, E. Werner, K. Grunewald, H. Wachter, and M. Hentze, 1994. Iron regulates nitric oxide synthase activity by controlling nuclear transcription. J. Exp. Med. 180:969-976.
6. Eitzman, D. T., R. D. McCoy, X. Zheng, W. P. Fay, T. Shen, D. Ginsburg, and R. H. Simon. 1996. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J. Clin. Invest. 97:232-237.
7. 2. Am. J. Pathol. 70:175-198.
8. Adamson, I. Y. R., and D. H. Bowden. 1974. The type 2 cell as progenitor of alveolar epithelial regeneration: a cytodynamic study in mice after exposure to oxygen. Lab. Invest. 30:35-42.
9. Marshall, B. C., D. S. Sageser, N. V. Rao, M. Emi, and J. R. Hoidal. 1990. Alveolar epithelial cell plasminogen activator characterization and regulation. J. Biol. Chem. 265:8198-8204.
10. Simon, R. H., T. J. Gross, J. A. Edwards, and R. G. Sitrin. 1992. Fibrin degradation by rat pulmonary alveolar epithelial cells. Am. J. physiol. 262: L482-L488.
11. Gross, T. J., R. H. Simon, C. J. Kelly, and R. G. Sitrin. 1991. Rat alveolar epithelial cells concomitantly express plasminogen activator inhibitor-1 and urokinase. Am. J. Physiol. 260:L286-L295.
12. Marshall, B. C., Q.-P. Xu, N. V. Rao, B. R. Brown, and J. R. Hoidal. 1992. Pulmonary epitheilal cell urokinase-type plasminogen activator: induction by interleukin-1 beta and tumor necrosis factor-alpha. J. Biol. Chem. 267: 11462-11469.
13. Hasegawa, T., L. Sorensen, M. Dohi, N. V. Rao, J. R. Hoidal, and B. C. Marshall. 1997. Induction of urokinase-type plasminogen activator receptor by IL-1β. Am. J. Respir. Cell Mol. Biol. 16:683-692.
14. Freedman, M., D. Grisaru, N. Olivieri, I. MacLusky, and P. Thorner. 1990. Pulmonary syndrome in patients with thalassemia major receiving intravenous deferoxamine infusions. Am. J. Dis. Child. 144:565-569.
15. Tenenhein, M., S. Kowalski, A. Sienko, D. Bowden, and I. Adamson. 1992. Pulmonary toxic effects of continuous desferrioxamine administration in acute iron poisoning. Lancet 339:699-701.
16. Stephens, R. W., J. Pollanen, H. Topiovaara, K.-C. Leung, P.-S. Sim, E.-M. Salonen, E. Ronne, N. Behrendt, K. Dano, and A. Vaheri. 1989. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants. J. Cell Biol. 108:1987-1995.
17. Leibold, E. A., and H. N. Munro. 1988. Cytoplasmic protein binds in vitro to a highly conserved sequence in the 5′ untranslated region of ferritin heavy and light-subunit mRNAs. Proc Natl. Acad. Sci. USA 85:2171-2175.
18. Leibold, E. A., and H. N. Munro. 1987. Characterization and evolution of the expressed rat liver ferritin light subunit gene and its pseudogene family: conservation of sequences within noncoding regions of ferritin genes. J. Biol. Chem. 262:7335-7341.
19. Greenberg, M., and T. Bender. 1993. Preparation and analysis of RNA. In Current Protocols in Molecular Biology. F. B. Ausubel, R. Kingston, D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl, editors. John Wiley and Sons, New York. 4.0.1-4.10.9.
20. Rao, K., J. Harford, T. Rouault, A. McClelland, F. Ruddle, and R. Klausner. 1986. Transcriptional regulation by iron of the gene for the transferrin receptor. Mol. Cell. Biol. 6:236-240.
21. White, K., and H. Munro. 1988. Induction of ferritin subunit synthesis by iron is regulated at both the transcriptional and translational levels. J. Biol. Chem. 263:8938-8942.
22. Alcantara, O., L. Obeid, and Y. Hannun. 1994. Regulation of protein kinase C (PKC) expression by iron: effect of different iron compounds on PKC-beta and PKC-alpha gene expression and role of the 5'-flanking region of the PKC-beta gene in the response to ferric transferrin. Blood 84:3510-3517.
23. Alcantara, O., S. Reddy, G. Roodman, and D. Boldt. 1994. Transcriptional regulation of the tartrate-resistant acid phosphatase (TRAP) gene by iron. Biochem. J. 298:421-425.
24. Fattal, P. G., D. J. Schneider, B. F. Sobel, and J. J. Billadello. 1992. Post-transcriptional regulation of expression of plasminogen activator inhibitor type 1 mRNA by insulin and insulin-like growth factor. J. Biol. Chem. 267: 12412-12415.
25. Bosma, P. J., and T. Kooistra. 1991. Differential induction of two plasminogen activator inhibitor 1 mRNA species by phorbol ester in human hepatoma cells. J. Biol. Chem. 266:17845-17849.
26. Binder, R., J. A. Horowitz, J. P. Basilion, D. M. Koeller, R. D. Klausner, and J. B. Harford. 1994. Evidence that the pathway of transferrin receptor mRNA degradation involves an endonucleolytic cleavage within the 3′ UTR and does not involve poly (A) tail shortening. EMBO J. 13:1969-1980.
27. Wang, G. L., and G. L. Semenza. 1993. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA binding activity: implications for model of hypoxia signal transduction. Blood 82: 3610-3615.
28. Goldberg, M. A., and T. J. Schneider. 1994. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J. Biol. Chem. 296:4355-4359.
29. Gleadle, J. M., B. L. Ebert, J. D. Firth, and P. J. Ratcliffe. 1995. Regulation of angiogenic growth factor expression by hypoxia, transition metals and chelating agents. Am. J. Physiol. 268:C1362-C1368.
30. Semenza, G. L., P. H. Roth, H.-M. Fang, and G. L. Wang. 1994. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269:23757-23763.
31. Ebert, B. L., J. D. Firth, and P. J. Ratcliffe. 1995. Hypoxia and mitochondrial inhibitors regulate expression of glucose transportor-1 via distinct cis-acting sequences. J. Biol. Chem. 270:29083-29089.
32. Graham, C. H., T. E. Fitzpatrick, and K. R. McCrae. 1998. Hypoxia stimulates urokinase receptor through a heme-dependent pathway. Blood 91: 3300-3307.
33. Mateos, F., J. H. Brock, and J. L. Perez-Arellano, 1998. Iron metabolism in the lower respiratory tract. Thorax 53:594-600.
34. Gutteridge, J. M., G. J. Ouinlan, and T. W. Evans. 1994. Transient iron overload with bleomycin detectable iron in the plasma of patients with adult respiratory distress syndrome. Thorax 49:707-710.
35. Hallman, M., A. Sarnesto, and K. Bry. 1994. Interaction of transferrin saturated with iron with lung surfactant in respiratory failure. J. Appl. Physiol. 77:757-766.
36. Thompson, A. B., T. Bohlin, A. Heires, J. Linder, and S. I. Rennard. 1991. Lower respiratory tract iron burden is increased in association with cigarette smoking. J. Lab. Clin. Med. 117:493-499.
37. Halliwell, B., and J. M. C. Gutteridge. 1981. Formation of a thiobarbiturie acid-reactive substance from deoxyribose in the presence of iron salts. FEBS Lett. 128:347-351.
38. Kennedy, T. P., N. V. Rao, W. Noah, J. R. Michael, M. H. Jafri, Jr., H. G. Gurtner, and J. R. Hoidal. 1990. Ibuprofen prevents oxidant lung injury and in vitro lipid peroxidation by chelating iron. J. Clin. Invest. 86:1565-1573.
39. Jones, R. I., 1986. Hematin-derived anticoagutant: generation in vitro and in vivo. J. Exp. Med. 163:724-739.